Keyphrases
Conjugate Vaccine
100%
Hypervirulent Klebsiella Pneumoniae
100%
Klebsiella Pneumoniae (K. pneumoniae)
50%
Hypervirulent
37%
Multidrug-resistant
25%
Glycoconjugate Vaccines
25%
Virulence
12%
Healthy Individuals
12%
Pathogenicity
12%
Life-threatening Infections
12%
Immunogenic
12%
Vaccine Target
12%
Community-acquired
12%
Lethal Dose
12%
Lethal Infection
12%
Overproduction
12%
Spawning
12%
Virulent Strain
12%
Carrier Protein
12%
Capsular Polysaccharide
12%
Analytical Characterization
12%
Glycoengineering
12%
Bioconjugates
12%
Antibiotic Susceptible
12%
Global Dissemination
12%
Superbugs
12%
Escherichia Coli Cells
12%
Recombinant Production
12%
Purified Polysaccharides
12%
Serotype K2
12%
Hypervirulence
12%
Hypervirulent K. Pneumoniae
12%
Chemical Methodology
12%
Serotype K1
12%
Pharmacology, Toxicology and Pharmaceutical Science
Klebsiella pneumoniae
100%
Infection
42%
Polysaccharide
28%
Glycoconjugate
28%
Escherichia coli
14%
Infectious Agent
14%
Preclinical Study
14%
Pathogenicity
14%
Klebsiella Pneumoniae Infection
14%
Immunology and Microbiology
Klebsiella pneumoniae
100%
Serotype
50%
Glycoconjugate
25%
Infectious Agent
12%
Escherichia coli
12%
Membrane Transport Protein
12%
Preclinical Study
12%
Spawning
12%
Pathogenicity
12%